Your browser is out-of-date!

Update your browser to view this website correctly.

Disclaimer
To continue, please select your country of domicile and investor type. Depending on your domicile and the investor type that you select, you will have full or restricted access to the information due to legal reasons.

Retail clients: according to Art. 4 Abs. 2 FinSA

Professional/Institutional investors: according to Art. 4 paragraph 3-5 and Art. 5 paragraph 1 and 3-4 FinSA and Art. 10 paragraph 3 and 3ter CISA in conjunction with Art. 6a CISO

Important

Principles 

By using the website www.bellevuehealthcaretrust.com, you confirm that you have read, understood and accepted the general information provided by the Bellevue Group AG as well as these legal provisions. These may be subject to change and the use of the site may be restricted or terminated at any time without prior notice.

The information, products, data, services, tools and documents contained or described on this site ("website content") are for information purposes only and constitute neither an advertisement or recommendation nor an offer or solicitation (to buy) or redemption (sell) investment instruments, to effect any transaction or to enter into any legal relations.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.

In order to determine whether the investment in shares of a certain investment fund meets your specific requirements and matches your envisaged risks, we recommend that you contact an independent financial adviser. Furthermore, we recommend that you consult an independent tax adviser in order to obtain information on the tax regulations relating to a specific investment in your legal jurisdiction and with regard to your personal circumstances. In particular tax treatment depends on individual circumstances and may be subject to change.

PERFORMANCE

Past performance is not an indication or guarantee of the future performance of the investment. The value of investments may be subject to fluctuations and, under certain circumstances, investors may not get back the full amount invested. Changes in foreign-exchange rates may also cause the value of investments to go up or down.

For a full explanation of risks and the overall risk profile of financial products mentioned on this site, please refer to the relevant Key Investor Information Documents (KIDs) and Prospectuses.

DATA PROTECTION

By accessing this website you state that you agree with the data protection statement. If you do not agree with this statement you should refrain from accessing any further pages of this website. This statement may be updated at any time. We therefore recommend that you check this statement regularly.

CONFIRMATION

By clicking on "Accept", you confirm that you agree to the legal provisions. Alternatively, you can select "I don't accept" if you wish to leave the website

This website uses cookies, which are necessary for the technical operation of the website and which are always set. Other cookies to personalize content and analyze access to our website are only set with your consent. We also share information about your use of our website with our social media, advertising and analytics partners.

Why invest in healthcare?

People in the United States spend USD 4.4 trillion on healthcare annually, that figure exceeds the combined GDP of the UK and the Netherlands. This spending is increasing due to an ageing population, a growing demand for personalised treatments, and rising healthcare costs. The US healthcare system, like those in other developed nations, is facing challenges with affordability, prompting calls for reform to improve outcomes and efficiency. Companies offering innovative solutions in this space are likely to see strong demand, particularly as the US market continues to grow and evolve with a focus on both public and private providers.

A megatrend and powerful innovation in one 

  • The world’s population is increasing and aging at the same time. Lifestyle diseases are on the rise worldwide. Households in emerging markets have become richer. Demand for healthcare products and services is increasing around the world in the wake of these developments.
  • The global growth of the healthcare industry has outpaced world GDP growth during the past decade.
  • Healthcare expenditure does not fluctuate much because there is little correlation between the underlying demand for healthcare and the economic cycle.
  • The innovative power in life sciences, driven by tremendous research and development efforts, makes this investment universe all the more attractive

  • 10.8%

    of global GDP goes to healthcare, 
    led by the US at 17.3% of GDP
     

  • USD 186 bn

    global spending on 
    pharmaceutical R&D in 2020
     

  • 55

    new drug approvals by the U.S. Food 
    and Drug Administration (FDA) in 2023, 
    the second highest number ever 

What does this mean for investors? 

The global megatrend of healthcare offers investors better-than-average long-term growth potential with an ideal risk/reward profile. Given the depth and breadth of the healthcare market, ranging from medicines and medical technology to healthcare services and other segments, it presents a more diverse range of investment opportunities than other sectors, on top of the attractive return potential. Because this market is so complex, an active fundamental-based investment approach is recommended, which makes a variety of promising and innovative investment strategies possible. The complexity and the dynamics of the healthcare market not only speak in favor of active investment management strategies, they also call for specific expertise in every area of the healthcare sector. 

Why invest in active management?

At Bellevue Healthcare Trust, we believe in the power of active management to unlock the growth potential in the healthcare sector. As an actively managed healthcare fund, our investment strategy focuses on identifying and capitalising on the exponential growth opportunities within the industry. By leveraging expert insights and in-depth analysis by our fund managers, we aim to deliver superior returns for our investors while navigating the dynamic landscape of healthcare innovation.

Why invest in Bellevue Healthcare Trust? 

Bellevue Healthcare Trust plc invests in 35 diverse healthcare companies, so it is highly concentrated and only targets businesses it knows in detail and who are poised to benefit from growing healthcare demand. Unrestricted by company size, sector, or location, the trust focuses solely on investments it believes will add value. It aims to deliver an annual dividend of 3.5% of net asset value, funded primarily from capital rather than just dividends.

Why Invest in a Closed-Ended UK Investment Trust?

For Institutional & Professional Investors

  • Permanent capital supports long-horizon strategies without daily liquidity pressures.
  • Access to illiquid asset classes including private markets and infrastructure.
  • Discount/premium arbitrage opportunities for tactical trading.
  • Board oversight adds governance not always found in other fund structures.
  • Gearing strategies unavailable in open-ended structures.

For Retail Investors

  • Access to diversified, actively managed portfolios.
  • Potential value from discounts on underlying assets.
  • Dividend reliability, even in volatile periods.
  • Liquidity: buy/sell anytime during market hours.
  • Low dealing costs through pooled investments.

Risks to Consider

  • Market Volatility: Discounts can widen during market stress.
  • Leverage Risk: Borrowing magnifies both gains and losses.
  • Liquidity Constraints: Smaller trusts may have limited trading volumes.
  • Structural Pressure: Prolonged discounts can trigger activist interventions or restructuring.

Conclusion:
The unique appeal of closed-end Investment Trusts

UK investment trusts are purpose-built for disciplined, long-term investing. Their closed-end structure eliminates the need to hold liquidity buffers, allowing portfolios to be fully invested at all times – often in differentiated assets unavailable to daily-dealing funds.

By combining professional asset management with the market accessibility of listed securities, investment trusts are a hybrid solution for investors who seek diversified exposure, income stability, and long-term capital growth. They require a bit more understanding – but in return, they offer an edge.

Explore Bellevue Healthcare Trust 

OSZAR »